Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has 'high- risk' disease?

Blood

Volumn 83, Issue 5, 1994, Pages 1165-1173

  Shipp, M A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN;

AGE; CANCER INVASION; CANCER SURVIVAL; COMBINATION CHEMOTHERAPY; DOSE RESPONSE; IMMUNOPHENOTYPING; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR GROWTH;

EID: 0028012062     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v83.5.1165.bloodjournal8351165     Document Type: Review

References (0)